SCHEMBL21921114

SCHEMBL21921114

CNC(C)c1cnc(OCC(F)(F)F)cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.38
CACNA1I Q9P0X4 3/20 0.37
CACNA1G O43497 2/20 0.37
CACNA1H O95180 2/20 0.37
CNR2 P34972 1/20 0.37
KCNH2 Q12809 1/20 0.37
CYP2C19 P33261 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
CYP1A2 P05177 2/20 0.35
EPHX2 P34913 2/20 0.33
POLB P06746 1/20 0.33
MAPK1 P28482 1/20 0.33
TRPV3 Q8NET8 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C9 P11712 1/20 0.32
CYP2J2 P51589 1/20 0.32
SCN9A Q15858 3/20 0.32
LMNA P02545 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21921818 0.89 ACACB (0.31)
SCHEMBL8055365 0.81 L3MBTL1 (0.40) L3MBTL1CACNA1ICACNA1GCACNA1HCNR2
SCHEMBL22811190 0.81 L3MBTL1 (0.40) L3MBTL1CACNA1ICACNA1GCACNA1HCNR2
Hydrochloric Acid SCHEMBL3037901 0.79 L3MBTL1 (0.39) L3MBTL1CACNA1ICACNA1GCACNA1HCNR2
SCHEMBL3038285 0.79 CACNA1G (0.33) L3MBTL1CACNA1ICACNA1GCACNA1HCNR2
SCHEMBL4550831 0.77 L3MBTL1 (0.47) L3MBTL1CACNA1ICACNA1GCACNA1HCNR2
SCHEMBL21600651 0.77 CACNA1I (0.58) CACNA1ICACNA1GCACNA1HCNR2KCNH2
Hydrochloric Acid SCHEMBL2719306 0.76 L3MBTL1 (0.46) L3MBTL1CACNA1ICACNA1GCACNA1HCNR2
SCHEMBL24468106 0.75 CYP2D6 (0.35) CYP2C19CYP2C9
SCHEMBL27180483 0.75 CYP2D6 (0.35) CYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3632899-A1 ARYL SUBSTITUTED CARBOXAMIDE DERIVATIVES AS CALCIUM OR SODIUM CHANNEL BLOCKERS RaQualia Pharma Inc. (JP) 2020-04-08 EP disclosed